BM

Biju Mappurath Karunakaran

Active Director Designated Partner DIN 10943198
DIN 10943198 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Biju Mappurath Karunakaran

Data last updated:

Biju Mappurath Karunakaran is a Designated Partner at Affluenza International Llp (since 2025).

DIN 10943198
Primary Designation Designated Partner
First Appointment 13 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Mar 20252024Active

Board colleagues of Biju Mappurath Karunakaran

NameDINCompanyDesignation
Ashik Ali Azar10830369Affluenza International LlpDesignated Partner
Parambath Thazhe Suja10943192Affluenza International LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Affluenza International Llp
Premium access

Shareholding and investment profile for Biju Mappurath Karunakaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biju Mappurath Karunakaran

Biju Mappurath Karunakaran currently holds 1 directorship: Affluenza International Llp (Designated Partner, since 13 Mar 2025).

Biju Mappurath Karunakaran was first appointed on 13 Mar 2025 as Designated Partner at Affluenza International Llp.

The current boards of Biju Mappurath Karunakaran's companies include Ashik Ali Azar (Affluenza International Llp), Parambath Thazhe Suja (Affluenza International Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available